LSE:SHEL
LSE:SHELOil and Gas

Has Shell’s Recent Pullback Opened the Door for Further Upside in 2025?

If you are wondering whether Shell remains attractive after its strong multi year run, or if the easy money has already been made, you are not alone. This breakdown addresses exactly that question. Despite a solid longer term record, with the share price up 12.9% over the last year and 143.5% over five years, Shell has cooled off recently, with a 1.9% drop in the past week and a 4.0% slide over the last month. Some of that pullback reflects shifting sentiment around oil prices and the...
NYSE:FINV
NYSE:FINVConsumer Finance

FinVolution Group (NYSE:FINV) Valuation After Capital-Light Shift and Fast-Growing International Expansion

FinVolution Group (FINV) is back in the spotlight after fresh coverage underscored its shift to a capital light consumer credit facilitator model, stronger international momentum and management’s renewed confidence in revenue growth into 2025. See our latest analysis for FinVolution Group. Despite the fresh enthusiasm, the stock’s 90 day share price return of negative 32.46% and year to date share price return of negative 23.89% show sentiment is still resetting. At the same time, the five...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

Why Power Solutions International (PSIX) Is Up 16.9% After Data-Center-Focused Power-Systems Pivot

Power Solutions International recently reported that its pivot toward higher-growth emission-certified power systems, especially for data centers, has driven substantial increases in 2025 net sales and net income, supported by a revised revolving credit facility and removal of prior going-concern uncertainty. This shift positions the company as a cash-generative integrator benefiting from surging on-site generation needs tied to AI and data-center expansion, creating a clearer operational...
SEHK:9926
SEHK:9926Biotechs

Assessing Akeso (SEHK:9926) After Its Strong Year-to-Date Rally and Recent Share Price Pullback

Akeso (SEHK:9926) has quietly turned into one of those stocks long term investors keep revisiting, with strong year to date gains despite recent pullbacks. This makes its current valuation worth a closer look. See our latest analysis for Akeso. That backdrop helps explain why a recent cool off in the share price, including a 4.0% one day share price pullback to HK$119.4, sits alongside a powerful year to date share price return of roughly 104%. Longer term total shareholder returns are still...
HLSE:KALMAR
HLSE:KALMARMachinery

Kalmar Oyj (HLSE:KALMAR) Expands Port Partnerships And EV Charging Ties – Is Its Moat Deepening?

In recent days Kalmar has announced a 10-year supply agreement with Patrick Terminals, a global RTCH distribution partnership with IRTC, and new DC fast-charging solutions with Kempower and SINEXCEL to support electric straddle carriers from 2026. Together, these moves deepen long-term customer ties, broaden Kalmar’s product reach into harsh environments, and reinforce its role in port decarbonisation infrastructure. We’ll now examine how the long-term Patrick Terminals agreement and broader...
TSX:CSU
TSX:CSUSoftware

Reassessing Constellation Software (TSX:CSU) Valuation After Founder CEO Mark Leonard’s Sudden Resignation

Constellation Software (TSX:CSU) is back in focus after founder Mark Leonard abruptly resigned as CEO for health reasons, with long time insider Mark Miller stepping in as President and joining the board. See our latest analysis for Constellation Software. The leadership news lands after a difficult stretch, with the 90 day share price return down sharply and the 1 year total shareholder return negative, even though 3 and 5 year total shareholder returns still show strong compounding. This...
NYSE:VST
NYSE:VSTRenewable Energy

Has Vistra’s AI Power Story Already Run Its Course After a 613% Surge?

Wondering if Vistra is still worth buying after its massive run, or if most of the upside is already baked into the price? Here is a closer look at what the current share price implies about its future. After an explosive multiyear climb of 613.3% over 3 years and 891.3% over 5 years, the stock has cooled off recently, slipping 4.5% in the last week and 13.7% over the past month, while still sitting on a 10.1% gain year to date and 17.1% over the last year. These moves are happening against...
NYSE:DHI
NYSE:DHIConsumer Durables

Does D.R. Horton’s Mixed Valuation Signal Opportunity After Recent Share Price Swings?

If you are wondering whether D.R. Horton at around $149 a share is a bargain or a value trap right now, you are not alone, and this breakdown is designed to address exactly that question. The stock is up 121.2% over five years and 76.2% over three years, but more recently it is down 5.7% over the last week, up 3.2% over the last month, and only 8.5% higher year to date. This suggests the market is rethinking its risk and growth expectations. Those swings are happening against a backdrop of...
NYSE:CDE
NYSE:CDEMetals and Mining

Coeur Mining (CDE) Valuation Check After Palmarejo’s Biggest Exploration Push Since 2012 and New Drill Success

Coeur Mining (CDE) just kicked off its biggest exploration push at Palmarejo since 2012, and early drilling hits at La Unión, Camuchín, Hidalgo, and San Miguel are quietly reshaping the long term resource picture. See our latest analysis for Coeur Mining. That exploration update lands after a huge run, with Coeur’s share price now at $16.07 and a powerful year to date share price return of 159.19 percent alongside a 1 year total shareholder return of 129.9 percent. This is signalling momentum...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Why Erie Indemnity (ERIE) Is Down 6.3% After Q3 EPS Beat But Revenue Miss - And What's Next

Earlier this week, Erie Indemnity reported third-quarter 2025 results with earnings per share of US$3.50 beating expectations, while revenue came in slightly below analyst estimates and trading conditions were broadly weak. Despite these pressures, the company remains profitable and has maintained an uninterrupted dividend record for 30 consecutive years, underscoring its income-focused appeal. With the share price recently experiencing a 6.27% weekly decline, we’ll consider how the revenue...
NYSE:EPAM
NYSE:EPAMIT

Is EPAM Systems a Recovery Story After Recent Share Price Rebound?

Wondering if EPAM Systems at around $208 is a recovery story or a value trap? You are not alone, and this piece is going to dig into what the current price really implies. The stock has bounced about 7.8% over the last week and 18.6% over the past month, even though it is still down 9.2% year to date and 16.8% over the last year, with a much steeper slide of 42.9% over three years and 36.2% over five years. Much of this recent volatility has been tied to shifting sentiment around IT services...
NYSE:AMC
NYSE:AMCEntertainment

AMC Entertainment (AMC) Valuation After Hycroft Stake Sale and Refocus on Core Theater Business

AMC Entertainment Holdings (AMC) has cashed in most of its Hycroft Mining stake, securing roughly $24.1 million in proceeds while keeping a smaller equity position and warrants, signaling a renewed focus on its core theater business. See our latest analysis for AMC Entertainment Holdings. The move to exit most of Hycroft comes after a tough stretch for shareholders, with a year to date share price return of negative 43.28 percent and a 1 year total shareholder return of negative 48.76...
NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

Ensign Group (ENSG): Assessing Valuation After a Strong Multi‑Year Run and Recent Share Price Pullback

Ensign Group (ENSG) has quietly outperformed many healthcare peers this year, so the stock now invites a closer look at whether its strong long term returns still leave room for further upside. See our latest analysis for Ensign Group. Recent trading has cooled slightly, with a modest pullback from recent highs even as Ensign holds near $174.14. However, the 90 day share price return and multi year total shareholder returns still point to sustained momentum rather than a reversal. If Ensign’s...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Has Summit Therapeutics Run Too Far After Its Huge Multi Year Share Price Surge?

If you are wondering whether Summit Therapeutics is still worth a closer look after its big run, or if you would just be buying into yesterday's hype, this article will walk you through what the current price really implies. Summit has cooled off recently, with the stock up 1.4% over the last week and 1.8% over the past month. However, that sits on top of a 469.6% gain over three years and 235.6% over five years, even though the 1 year return is slightly negative at 0.8%. Those moves have...
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

AvePoint (AVPT) Is Up 6.6% After Analyst Upgrades and Top Zacks Rank Signal Renewed Optimism

Recently, analysts have raised their earnings estimates for AvePoint, and the stock has received a top Zacks Rank, reflecting stronger confidence in its profit outlook. This shift follows an earlier post-earnings setback highlighted by Voya Investment Management, underscoring how changing sentiment and short interest trends can rapidly reshape perceptions of AvePoint’s prospects. Next, we’ll examine how this renewed analyst optimism around AvePoint’s earnings outlook influences the company’s...
NasdaqCM:LE
NasdaqCM:LESpecialty Retail

Lands’ End (LE) Q3 Profit Rebound Reinforces Bullish Turnaround Narrative

Lands' End (LE) has just posted Q3 2026 results with revenue of about $317.5 million and basic EPS of $0.17, putting a clear profit on the board for the quarter. The company has seen quarterly revenue hold around the low $300 million mark over the last few periods, while basic EPS has swung from losses of roughly $0.27 and $0.17 earlier in 2026 to a modest profit this quarter, setting up a story that is increasingly about how much of that top line can translate into sustainable margins. See...
NYSE:BMY
NYSE:BMYPharmaceuticals

Taking Stock of Bristol-Myers Squibb (BMY): Exploring Valuation After Recent Share Price Momentum

Bristol-Myers Squibb (BMY) has quietly pushed higher over the past month, even as its longer term returns remain underwhelming. That mix of recent momentum and lagging history is exactly what makes the stock interesting now. See our latest analysis for Bristol-Myers Squibb. Over the past year, Bristol-Myers Squibb’s share price return has been negative, but the recent 1 month and 3 month share price gains suggest sentiment is cautiously improving as investors reassess its pipeline and...
NYSE:AS
NYSE:ASLuxury

Assessing Amer Sports (NYSE:AS) Valuation After Its Strong Year-to-Date Share Price Rally

Amer Sports (NYSE:AS) has quietly put together a strong run, with the stock climbing about 34% year to date and roughly 51% over the past year as revenue and earnings growth pick up. See our latest analysis for Amer Sports. That move has been reinforced by a sharp 30 day share price return of about 31% and a 1 year total shareholder return just over 50%, suggesting momentum is building as investors lean into its growth story. If Amer Sports’ run has you thinking about what else could surprise...
TSX:BB
TSX:BBSoftware

Is BlackBerry A Value Opportunity After Recent Cybersecurity Pivot And Share Price Rebound?

If you are wondering whether BlackBerry is quietly turning into a value opportunity after years in the wilderness, this piece will walk through whether the current share price still leaves upside on the table. The stock has had a choppy ride, up 7.9% over the last week and 11.1% year to date. That sits alongside a 54.2% gain over the past year and a still hefty 42.0% decline over five years. Recently, investors have been refocusing on BlackBerry’s pivot toward cybersecurity software and...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Is Papa Johns Stock Pricing In Too Much Optimism After Years of Share Price Declines?

If you are wondering whether Papa John's International at around $40.96 is a quietly mispriced opportunity or a value trap in plain sight, this breakdown is for you. The stock is down about 2.8% over the last week, roughly flat over the past month, and still sitting on a 10.5% slide over the past year and a steep 48.2% drop over three years, which indicates sentiment has been under pressure for a while. Recent headlines have focused on Papa John's ongoing strategy tweaks, from sharpening its...
NYSE:DOCN
NYSE:DOCNIT

DigitalOcean (DOCN): Assessing Valuation After Paperspace Deal and Rapid Growth in Direct AI Revenue

DigitalOcean Holdings (DOCN) is back in focus after its Paperspace acquisition, a deal aimed squarely at beefing up AI infrastructure just as the company more than doubled its direct AI revenue and locked in extra data center capacity. See our latest analysis for DigitalOcean Holdings. That AI push seems to be resonating, with the 90 day share price return of 45.42 percent and a 1 year total shareholder return of 29.85 percent signalling that momentum is building rather than fading. If you...
NYSE:IBM
NYSE:IBMIT

Is It Too Late to Consider IBM After Its Strong AI Focused Share Price Rally?

How Has IBM Stock Been Performing Lately International Business Machines has been on many investors watchlists lately, raising the question of whether its current share price offers real value or if most of the upside has already been captured. With a long history and a renewed focus on hybrid cloud and AI, IBM is again at the center of the value versus growth debate. Over the last year, IBM shares have delivered a strong 37.5% return, with gains of 2.9% over the past week and 1.3% over the...